Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection

Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chron...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 472
Main Authors Yong, Yean K., Saeidi, Alireza, Tan, Hong Y., Rosmawati, Mohamed, Enström, Philip F., Batran, Rami Al, Vasuki, V., Chattopadhyay, Indranil, Murugesan, Amudhan, Vignesh, Ramachandran, Kamarulzaman, Adeeba, Rajarajeswaran, Jayakumar, Ansari, Abdul W., Vadivelu, Jamuna, Ussher, James E., Velu, Vijayakumar, Larsson, Marie, Shankar, Esaki M.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 19.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3 CD161 TCR iVα7.2 MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2 CD161 MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4 T cells and MAIT cells and with CD57 on CD8 T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2 MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.
AbstractList Mucosal-associated invariant T (MAIT) cells, defined as CD161 ++ TCR iVα7.2 + T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3 + CD161 ++ TCR iVα7.2 + MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2 + CD161 + MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4 + T cells and MAIT cells and with CD57 on CD8 + T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2 + MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.
Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.
Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.
Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3 CD161 TCR iVα7.2 MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2 CD161 MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4 T cells and MAIT cells and with CD57 on CD8 T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2 MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.
Author Murugesan, Amudhan
Vadivelu, Jamuna
Velu, Vijayakumar
Ansari, Abdul W.
Batran, Rami Al
Vignesh, Ramachandran
Shankar, Esaki M.
Tan, Hong Y.
Larsson, Marie
Enström, Philip F.
Chattopadhyay, Indranil
Ussher, James E.
Rajarajeswaran, Jayakumar
Kamarulzaman, Adeeba
Saeidi, Alireza
Rosmawati, Mohamed
Vasuki, V.
Yong, Yean K.
AuthorAffiliation 1 Laboratory Center, Xiamen University Malaysia , Sepang , Malaysia
14 Department of Microbiology and Immunology, Emory Vaccine Center , Atlanta, GA , United States
9 The Government Theni Medical College and Hospital , Theni , India
15 Division of Infection Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India
10 Laboratory-Based Department, Universiti Kuala Lumpur , Ipoh , Malaysia
3 China-ASEAN Institute of Marine Science (CAMS), Xiamen University Malaysia , Sepang , Malaysia
7 Department of Microbiology, The Government Thiruvarur Medical College and Hospital , Thiruvarur , India
11 Center of Excellence for Research in AIDS, University of Malaya , Kuala Lumpur , Malaysia
2 Department of Medicine, University of Malaya Medical Centre , Kuala Lumpur , Malaysia
4 Department of Traditional Chinese Medicine, Xiamen University Malaysia , Sepang , Malaysia
12 Department of Molecular Medicine, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia
6 Dep
AuthorAffiliation_xml – name: 4 Department of Traditional Chinese Medicine, Xiamen University Malaysia , Sepang , Malaysia
– name: 6 Department of Medical Microbiology, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia
– name: 8 Division of Molecular Cancer Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India
– name: 3 China-ASEAN Institute of Marine Science (CAMS), Xiamen University Malaysia , Sepang , Malaysia
– name: 10 Laboratory-Based Department, Universiti Kuala Lumpur , Ipoh , Malaysia
– name: 5 Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University , Linköping , Sweden
– name: 14 Department of Microbiology and Immunology, Emory Vaccine Center , Atlanta, GA , United States
– name: 12 Department of Molecular Medicine, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia
– name: 15 Division of Infection Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India
– name: 1 Laboratory Center, Xiamen University Malaysia , Sepang , Malaysia
– name: 7 Department of Microbiology, The Government Thiruvarur Medical College and Hospital , Thiruvarur , India
– name: 11 Center of Excellence for Research in AIDS, University of Malaya , Kuala Lumpur , Malaysia
– name: 16 Department of Microbiology, Central University of Tamil Nadu , Thiruvarur , India
– name: 13 Department of Microbiology and Immunology, University of Otago , Dunedin , New Zealand
– name: 2 Department of Medicine, University of Malaya Medical Centre , Kuala Lumpur , Malaysia
– name: 9 The Government Theni Medical College and Hospital , Theni , India
Author_xml – sequence: 1
  givenname: Yean K.
  surname: Yong
  fullname: Yong, Yean K.
– sequence: 2
  givenname: Alireza
  surname: Saeidi
  fullname: Saeidi, Alireza
– sequence: 3
  givenname: Hong Y.
  surname: Tan
  fullname: Tan, Hong Y.
– sequence: 4
  givenname: Mohamed
  surname: Rosmawati
  fullname: Rosmawati, Mohamed
– sequence: 5
  givenname: Philip F.
  surname: Enström
  fullname: Enström, Philip F.
– sequence: 6
  givenname: Rami Al
  surname: Batran
  fullname: Batran, Rami Al
– sequence: 7
  givenname: V.
  surname: Vasuki
  fullname: Vasuki, V.
– sequence: 8
  givenname: Indranil
  surname: Chattopadhyay
  fullname: Chattopadhyay, Indranil
– sequence: 9
  givenname: Amudhan
  surname: Murugesan
  fullname: Murugesan, Amudhan
– sequence: 10
  givenname: Ramachandran
  surname: Vignesh
  fullname: Vignesh, Ramachandran
– sequence: 11
  givenname: Adeeba
  surname: Kamarulzaman
  fullname: Kamarulzaman, Adeeba
– sequence: 12
  givenname: Jayakumar
  surname: Rajarajeswaran
  fullname: Rajarajeswaran, Jayakumar
– sequence: 13
  givenname: Abdul W.
  surname: Ansari
  fullname: Ansari, Abdul W.
– sequence: 14
  givenname: Jamuna
  surname: Vadivelu
  fullname: Vadivelu, Jamuna
– sequence: 15
  givenname: James E.
  surname: Ussher
  fullname: Ussher, James E.
– sequence: 16
  givenname: Vijayakumar
  surname: Velu
  fullname: Velu, Vijayakumar
– sequence: 17
  givenname: Marie
  surname: Larsson
  fullname: Larsson, Marie
– sequence: 18
  givenname: Esaki M.
  surname: Shankar
  fullname: Shankar, Esaki M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29616020$$D View this record in MEDLINE/PubMed
BookMark eNp1kt9u0zAUxiM0xMbYPVfIl0hViv_ESXqDtKWFVipiQtVuLcc5aT2ldrGdsj4WLwKvhNtuqEPCN7bO-c7vk46_18mZsQaS5C3BQ8bK0YdWr9f9kGJSDjHOCvoiuSB5nqWM0uzs5H2eXHl_j-PJRowx_io5p6Oc5Jjii-T3dLcBl04eNg6819Yg26LbcUrQzKNr763SMkCDfuiwQmEFaA5b6PxeNXlYyd7vm9I0aLzzbW9UiAjZodsVGBsi-qCstFN9J4M2S1SNSU4Gg0X1Dem7Xz-LIR2gL72yXnbpid_MbKXT0gS0QBV00VEbVK2cNVqhKWwiLGiPbtCddr2P8hYO3m-Sl63sPFw93pfJ4tNkUU3T-dfPs-p6nio2oiElGNqyoDXkdT3ikmKgdc05kdAywOWoLIHThhUYCK-blpNcUeC4zWoGBZPsMpkdsY2V92Lj9Fq6nbBSi0PBuqWQLmjVgWANRINIUpRnkhd1ITFtikY2pIm_UUfWxyNr09draBSY4GT3DPq8Y_RKLO1W8DIvM84j4P0jwNnvPfgg1tqruDRpwPZeUExJwSjJ99J3p15_TZ4CEQX5UaCc9d5BK5QOcr_ZaK07QbDYh08cwif24ROH8MVB_M_gE_u_I38AvpLgpQ
CitedBy_id crossref_primary_10_1089_gtmb_2018_0092
crossref_primary_10_1016_j_virs_2023_10_007
crossref_primary_10_1371_journal_pone_0303945
crossref_primary_10_1016_j_coviro_2021_04_003
crossref_primary_10_1186_s12935_022_02703_x
crossref_primary_10_3390_cancers13071502
crossref_primary_10_1186_s12958_019_0524_5
crossref_primary_10_1007_s00430_018_0547_0
crossref_primary_10_1111_exd_13952
crossref_primary_10_1093_cei_uxad102
crossref_primary_10_3389_fimmu_2019_01888
crossref_primary_10_1016_j_molimm_2018_08_022
crossref_primary_10_3389_fimmu_2020_00490
crossref_primary_10_1155_2019_1356540
crossref_primary_10_1002_1873_3468_13488
crossref_primary_10_3389_fcimb_2024_1488527
crossref_primary_10_1038_s41590_019_0444_8
crossref_primary_10_1136_jitc_2021_003685
crossref_primary_10_3389_fimmu_2019_03053
crossref_primary_10_1002_ijc_33411
crossref_primary_10_1186_s12985_022_01777_3
crossref_primary_10_1016_j_isci_2024_108801
crossref_primary_10_1080_1744666X_2023_2198209
crossref_primary_10_1111_liv_15445
crossref_primary_10_14309_ctg_0000000000000052
crossref_primary_10_3389_fimmu_2020_01961
crossref_primary_10_3390_ijms21072379
crossref_primary_10_1111_jvh_13108
crossref_primary_10_1111_liv_15054
crossref_primary_10_3389_fimmu_2020_01691
crossref_primary_10_1186_s12935_018_0627_7
crossref_primary_10_3390_vaccines11030681
crossref_primary_10_1186_s40425_019_0749_z
crossref_primary_10_1089_vim_2020_0149
crossref_primary_10_3389_fimmu_2022_931764
crossref_primary_10_5812_hepatmon_94377
crossref_primary_10_1111_jvh_13341
crossref_primary_10_1111_jvh_13040
crossref_primary_10_1016_j_molimm_2020_12_007
crossref_primary_10_3748_wjg_v27_i25_3790
crossref_primary_10_1186_s12958_021_00861_7
crossref_primary_10_3389_fimmu_2019_03127
crossref_primary_10_3390_cancers13184647
crossref_primary_10_3390_vaccines13020155
crossref_primary_10_3389_fmicb_2022_975584
crossref_primary_10_3748_wjg_v27_i25_3705
crossref_primary_10_1158_1078_0432_CCR_18_3040
crossref_primary_10_1089_dna_2018_4278
crossref_primary_10_1371_journal_pone_0228302
crossref_primary_10_4049_jimmunol_2100522
crossref_primary_10_3390_cancers12020413
crossref_primary_10_1186_s13578_021_00664_8
crossref_primary_10_1016_j_micpath_2021_105231
crossref_primary_10_1093_jleuko_qiad129
crossref_primary_10_1016_j_ebiom_2024_105138
crossref_primary_10_1016_j_jcmgh_2022_12_014
crossref_primary_10_3748_wjg_v26_i31_4703
crossref_primary_10_3389_fimmu_2018_02569
crossref_primary_10_3389_fimmu_2023_1160943
crossref_primary_10_1038_s41598_020_69358_4
crossref_primary_10_3390_cancers13030404
crossref_primary_10_3390_microorganisms9020296
crossref_primary_10_1016_j_smim_2022_101661
crossref_primary_10_1016_j_jhepr_2023_100812
crossref_primary_10_1186_s40364_023_00482_9
crossref_primary_10_3389_fonc_2021_731175
crossref_primary_10_3389_fimmu_2023_1114605
crossref_primary_10_1007_s00281_022_00949_1
crossref_primary_10_3390_v12091051
crossref_primary_10_1002_jmv_29142
Cites_doi 10.1186/1471-230X-12-109
10.1053/jhep.2003.50208
10.1177/1753425917714854
10.1371/journal.pone.0136476
10.1073/pnas.0903196106
10.1189/jlb.4RU0216-084R
10.1002/hep.22956
10.1002/eji.201141852
10.1016/j.jhep.2008.08.026
10.1016/j.cellimm.2015.10.009
10.1111/eci.12581
10.1073/pnas.0914839107
10.1084/jem.20022235
10.1038/nature11605
10.1128/JVI.02844-06
10.1136/gutjnl-2011-301073
10.1097/MD.0000000000001134
10.1111/j.1572-0241.2006.00647.x
10.1056/NEJMoa043470
10.1002/hep.23173
10.1371/journal.pone.0105703
10.1371/journal.ppat.1004210
10.1016/S0140-6736(12)61728-0
10.1136/gut.2006.093906
10.1038/ncomms4866
10.1371/journal.pone.0124659
10.1016/j.virol.2014.12.033
10.1002/hep.23936
10.1016/j.apsb.2014.05.002
10.4049/jimmunol.178.10.6634
10.3748/wjg.v13.i14.2104
10.1016/S0168-8278(01)00028-9
10.1084/jem.20112095
10.1093/carcin/bgm252
10.1046/j.1440-1746.2003.02976.x
10.1073/pnas.0406282101
10.3748/wjg.14.3059
10.1016/j.cellimm.2015.05.005
10.1002/hep.24249
10.1002/eji.201343509
10.1038/ni1515
10.1371/journal.pone.0077780
10.1371/journal.pone.0047648
10.1182/blood-2010-08-303339
10.1056/NEJMra031087
10.1016/j.vaccine.2007.09.072
10.1038/ni.1679
10.1182/blood-2012-06-436436
10.1053/j.gastro.2005.11.016
10.1038/nature04444
10.1038/ni.3298
10.1038/mi.2014.81
10.1111/j.1365-2893.2005.00603.x
10.1371/journal.ppat.1003784
10.1016/j.coi.2013.01.005
10.1182/blood-2010-11-317297
10.1038/nature13160
10.1093/jnci/djn243
10.4254/wjh.v7.i12.1660
ContentType Journal Article
Copyright Copyright © 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar. 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar
Copyright_xml – notice: Copyright © 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar. 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2018.00472
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_3de5a270ec254a57b7a02d7dad1d335b
PMC5868455
29616020
10_3389_fimmu_2018_00472
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Institut Pengurusan dan Pemantauan Penyelidikan, Universiti Malaya
  grantid: FG019-17AFR
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c392t-10ef872be6bb95a20e2bb551aef3e08988e52d370e15bdf516c2e50f4b3e73a3
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:23:48 EDT 2025
Thu Aug 21 17:23:51 EDT 2025
Thu Jul 10 18:34:46 EDT 2025
Mon Jul 21 05:59:49 EDT 2025
Tue Jul 01 01:35:18 EDT 2025
Thu Apr 24 22:59:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords immunosenescence
HLA-DR
HBV infection
mucosal-associated invariant T cells
CTLA-4
immune exhaustion
PD-1
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c392t-10ef872be6bb95a20e2bb551aef3e08988e52d370e15bdf516c2e50f4b3e73a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Reviewed by: Masaaki Miyazawa, Kindai University, Japan; Hridayesh Prakash, All India Institute of Medical Sciences, India
These authors have contributed equally to the experimental work and writing of the manuscript.
Edited by: Jason Paul Gigley, University of Wyoming, United States
Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.00472
PMID 29616020
PQID 2021732165
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_3de5a270ec254a57b7a02d7dad1d335b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5868455
proquest_miscellaneous_2021732165
pubmed_primary_29616020
crossref_citationtrail_10_3389_fimmu_2018_00472
crossref_primary_10_3389_fimmu_2018_00472
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-19
PublicationDateYYYYMMDD 2018-03-19
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-19
  day: 19
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2018
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Kjer-Nielsen (B40) 2012; 491
Said (B9) 2015; 7
Chen (B48) 2007; 178
Pol (B3) 2001; 34
Vandepapeliere (B4) 2007; 25
Le Bourhis (B19) 2013; 25
B28
Blackburn (B35) 2009; 10
Wenjin (B33) 2012; 12
Chen (B54) 2006; 101
Barber (B50) 2006; 439
Liu (B57) 2008; 14
Godfrey (B45) 2015; 16
Loggi (B11) 2009; 50
Boni (B13) 2007; 81
Liaw (B32) 2003; 18
Ussher (B43) 2014; 44
Perrillo (B5) 2009; 49
Lau (B6) 2005; 352
Bertoletti (B8) 2012; 61
Nebbia (B15) 2012; 7
Barathan (B27) 2016; 46
Saeidi (B39) 2016; 100
Iloeje (B55) 2006; 130
Lozano (B1) 2012; 380
Kahan (B31) 2015; 47
Wu (B16) 2012; 42
Chen (B12) 2004; 101
Mommeja-Marin (B59) 2003; 37
Saeidi (B30) 2015; 297
Yuan (B53) 2005; 12
Yang (B58) 2008; 100
Quan (B51) 2015; 10
Reantragoon (B20) 2012; 209
Yamamoto (B37) 2011; 117
Kurioka (B44) 2015; 8
Lepore (B21) 2014; 5
Jo (B42) 2014; 10
Cosgrove (B23) 2013; 121
Wu (B56) 2008; 29
Raziorrouh (B38) 2014; 9
Ganem (B10) 2004; 350
Corbett (B41) 2014; 509
Huang (B18) 2009; 106
Karrar (B47) 2007; 56
Seung (B52) 2013; 8
Saeidi (B29) 2015; 10
Yong (B26) 2017; 23
Raziorrouh (B34) 2010; 52
Kassel (B49) 2009; 50
Shao (B60) 2007; 13
Kaufmann (B36) 2007; 8
Billerbeck (B22) 2010; 107
Dusseaux (B17) 2011; 117
Ussher (B24) 2015; 94
Saeidi (B25) 2015; 298
Iwai (B46) 2003; 198
Chang (B7) 2014; 4
Bertoletti (B2) 2013; 9
Schurich (B14) 2011; 53
References_xml – volume: 12
  start-page: 109
  year: 2012
  ident: B33
  article-title: Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-12-109
– volume: 37
  start-page: 1309
  year: 2003
  ident: B59
  article-title: Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50208
– volume: 23
  start-page: 459
  year: 2017
  ident: B26
  article-title: Decrease of CD69 levels on TCR Valpha7.2(+)CD4(+) innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients
  publication-title: Innate Immun
  doi: 10.1177/1753425917714854
– volume: 10
  start-page: e0136476
  year: 2015
  ident: B51
  article-title: PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell lymphoma in vitro
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0136476
– volume: 106
  start-page: 8290
  year: 2009
  ident: B18
  article-title: MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0903196106
– volume: 100
  start-page: 305
  year: 2016
  ident: B39
  article-title: Functional role of mucosal-associated invariant T cells in HIV infection
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.4RU0216-084R
– volume: 49
  start-page: S103
  year: 2009
  ident: B5
  article-title: Benefits and risks of interferon therapy for hepatitis B
  publication-title: Hepatology
  doi: 10.1002/hep.22956
– volume: 42
  start-page: 1180
  year: 2012
  ident: B16
  article-title: Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201141852
– volume: 50
  start-page: 625
  year: 2009
  ident: B11
  article-title: Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.08.026
– volume: 298
  start-page: 126
  year: 2015
  ident: B25
  article-title: Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2015.10.009
– volume: 46
  start-page: 170
  year: 2016
  ident: B27
  article-title: Peripheral loss of CD8(+) CD161(++) TCRValpha7.2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients
  publication-title: Eur J Clin Invest
  doi: 10.1111/eci.12581
– volume: 107
  start-page: 3006
  year: 2010
  ident: B22
  article-title: Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0914839107
– volume: 198
  start-page: 39
  year: 2003
  ident: B46
  article-title: PD-1 inhibits antiviral immunity at the effector phase in the liver
  publication-title: J Exp Med
  doi: 10.1084/jem.20022235
– volume: 491
  start-page: 717
  year: 2012
  ident: B40
  article-title: MR1 presents microbial vitamin B metabolites to MAIT cells
  publication-title: Nature
  doi: 10.1038/nature11605
– volume: 81
  start-page: 4215
  year: 2007
  ident: B13
  article-title: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
  publication-title: J Virol
  doi: 10.1128/JVI.02844-06
– volume: 61
  start-page: 1754
  year: 2012
  ident: B8
  article-title: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
  publication-title: Gut
  doi: 10.1136/gutjnl-2011-301073
– volume: 94
  start-page: e1134
  year: 2015
  ident: B24
  article-title: Molecular analyses define Valpha7.2-Jalpha33+ MAIT cell depletion in HIV infection: a case-control study
  publication-title: Medicine
  doi: 10.1097/MD.0000000000001134
– volume: 101
  start-page: 1797
  year: 2006
  ident: B54
  article-title: Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2006.00647.x
– volume: 352
  start-page: 2682
  year: 2005
  ident: B6
  article-title: Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043470
– ident: B28
– volume: 50
  start-page: 1625
  year: 2009
  ident: B49
  article-title: Chronically inflamed livers up-regulate expression of inhibitory B7 family members
  publication-title: Hepatology
  doi: 10.1002/hep.23173
– volume: 9
  start-page: e105703
  year: 2014
  ident: B38
  article-title: Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0105703
– volume: 10
  start-page: e1004210
  year: 2014
  ident: B42
  article-title: Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004210
– volume: 380
  start-page: 2095
  year: 2012
  ident: B1
  article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61728-0
– volume: 56
  start-page: 243
  year: 2007
  ident: B47
  article-title: Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction
  publication-title: Gut
  doi: 10.1136/gut.2006.093906
– volume: 5
  start-page: 3866
  year: 2014
  ident: B21
  article-title: Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire
  publication-title: Nat Commun
  doi: 10.1038/ncomms4866
– volume: 10
  start-page: e0124659
  year: 2015
  ident: B29
  article-title: Attrition of TCR Valpha7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0124659
– volume: 47
  start-page: 180
  year: 2015
  ident: B31
  article-title: T cell exhaustion during persistent viral infections
  publication-title: Virology
  doi: 10.1016/j.virol.2014.12.033
– volume: 52
  start-page: 1934
  year: 2010
  ident: B34
  article-title: The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function
  publication-title: Hepatology
  doi: 10.1002/hep.23936
– volume: 4
  start-page: 248
  year: 2014
  ident: B7
  article-title: Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2014.05.002
– volume: 178
  start-page: 6634
  year: 2007
  ident: B48
  article-title: B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.10.6634
– volume: 13
  start-page: 2104
  year: 2007
  ident: B60
  article-title: Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i14.2104
– volume: 34
  start-page: 917
  year: 2001
  ident: B3
  article-title: Efficacy and limitations of a specific immunotherapy in chronic hepatitis B
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(01)00028-9
– volume: 209
  start-page: 761
  year: 2012
  ident: B20
  article-title: Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor
  publication-title: J Exp Med
  doi: 10.1084/jem.20112095
– volume: 29
  start-page: 106
  year: 2008
  ident: B56
  article-title: Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm252
– volume: 18
  start-page: 246
  year: 2003
  ident: B32
  article-title: Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy
  publication-title: J Gastroenterol Hepatol
  doi: 10.1046/j.1440-1746.2003.02976.x
– volume: 101
  start-page: 14913
  year: 2004
  ident: B12
  article-title: A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0406282101
– volume: 14
  start-page: 3059
  year: 2008
  ident: B57
  article-title: A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.3059
– volume: 297
  start-page: 19
  year: 2015
  ident: B30
  article-title: Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2015.05.005
– volume: 53
  start-page: 1494
  year: 2011
  ident: B14
  article-title: Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
  publication-title: Hepatology
  doi: 10.1002/hep.24249
– volume: 44
  start-page: 195
  year: 2014
  ident: B43
  article-title: CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343509
– volume: 8
  start-page: 1246
  year: 2007
  ident: B36
  article-title: Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
  publication-title: Nat Immunol
  doi: 10.1038/ni1515
– volume: 8
  start-page: e77780
  year: 2013
  ident: B52
  article-title: PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0077780
– volume: 7
  start-page: e47648
  year: 2012
  ident: B15
  article-title: Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0047648
– volume: 117
  start-page: 1250
  year: 2011
  ident: B17
  article-title: Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
  publication-title: Blood
  doi: 10.1182/blood-2010-08-303339
– volume: 350
  start-page: 1118
  year: 2004
  ident: B10
  article-title: Hepatitis B virus infection – natural history and clinical consequences
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra031087
– volume: 25
  start-page: 8585
  year: 2007
  ident: B4
  article-title: Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.09.072
– volume: 10
  start-page: 29
  year: 2009
  ident: B35
  article-title: Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
  publication-title: Nat Immunol
  doi: 10.1038/ni.1679
– volume: 121
  start-page: 951
  year: 2013
  ident: B23
  article-title: Early and nonreversible decrease of CD161++/MAIT cells in HIV infection
  publication-title: Blood
  doi: 10.1182/blood-2012-06-436436
– volume: 130
  start-page: 678
  year: 2006
  ident: B55
  article-title: Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.11.016
– volume: 439
  start-page: 682
  year: 2006
  ident: B50
  article-title: Restoring function in exhausted CD8 T cells during chronic viral infection
  publication-title: Nature
  doi: 10.1038/nature04444
– volume: 16
  start-page: 1114
  year: 2015
  ident: B45
  article-title: The burgeoning family of unconventional T cells
  publication-title: Nat Immunol
  doi: 10.1038/ni.3298
– volume: 8
  start-page: 429
  year: 2015
  ident: B44
  article-title: MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2014.81
– volume: 12
  start-page: 373
  year: 2005
  ident: B53
  article-title: The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B
  publication-title: J Viral Hepat
  doi: 10.1111/j.1365-2893.2005.00603.x
– volume: 9
  start-page: e1003784
  year: 2013
  ident: B2
  article-title: Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003784
– volume: 25
  start-page: 174
  year: 2013
  ident: B19
  article-title: MAIT cells, surveyors of a new class of antigen: development and functions
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2013.01.005
– volume: 117
  start-page: 4805
  year: 2011
  ident: B37
  article-title: Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
  publication-title: Blood
  doi: 10.1182/blood-2010-11-317297
– volume: 509
  start-page: 361
  year: 2014
  ident: B41
  article-title: T-cell activation by transitory neo-antigens derived from distinct microbial pathways
  publication-title: Nature
  doi: 10.1038/nature13160
– volume: 100
  start-page: 1134
  year: 2008
  ident: B58
  article-title: Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djn243
– volume: 7
  start-page: 1660
  year: 2015
  ident: B9
  article-title: Induced immunity against hepatitis B virus
  publication-title: World J Hepatol
  doi: 10.4254/wjh.v7.i12.1660
SSID ssj0000493335
Score 2.4559822
Snippet Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections,...
Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections,...
Mucosal-associated invariant T (MAIT) cells, defined as CD161 ++ TCR iVα7.2 + T cells, play an important role in the innate defense against bacterial...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 472
SubjectTerms HBV infection
HLA-DR
immune exhaustion
Immunology
immunosenescence
mucosal-associated invariant T cells
PD-1
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELbQSkhcEP-UP3klLqgKje04To5s21UXsWiFympvURxPaFDXRU2Ldh-LF4FXYiZJq3aF4MI1nmgszzjzjf1lhrHXOiysEGADUFEURFq4wCaJDkKA0qQOpHL0v_Ppx3jyOXp_oS92Wn0RJ6wtD9wu3EA50Lk0IRSYyuTaWJOH0hmXO-GU0pa-vhjzdpKpry3uVTja3ktiFpYOyuryck1ULuJORkbuxaGmXP-fMOZNquRO7Dm-x-52oJG_ayd7n90C_4DdbttIXj9kvyaYTC6D8VVHavV8UfKzUSD4Sc036w-O05krR8DHPxBTqCap8dWMCv_gYO4dH13XFOfa40F-NgO_oCPaRnJYLYum1Zf_wocjRHD9_nT4iVfnP3-Yt7LPT4n6ns-DHX0n_jtm4mg6PuVDmKPGyvOuGi-fAHG5V1XNj_h5tVzXKN7ywvwjNj0eT4eToGvUEBQIr1b4KYcyMdJCbG2K1gpBWotQLIdSQZikSQJaOoVGFNq6Uou4kKDDMrIKjMrVY3bgFx6eMh4WkUhCJcvUCErurHR5qqOiMIkFaUyPDTZWy4quiDn10phnmMyQnbPGzhnZOWvs3GNvtm98awt4_EX2iBxhK0elt5sH6JBZ55DZvxyyxw43bpThVqX7l9zDYl2jIsz_lBSx7rEnrVttVck0FjFC9x4zew63N5f9EV_NmnLgOomTSOtn_2Pyz9kdWg4i2Yn0BTtYLdfwElHXyr5qNthvwBUu_Q
  priority: 102
  providerName: Directory of Open Access Journals
Title Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/29616020
https://www.proquest.com/docview/2021732165
https://pubmed.ncbi.nlm.nih.gov/PMC5868455
https://doaj.org/article/3de5a270ec254a57b7a02d7dad1d335b
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fb9MwELfQEBIviP-UP5OReEFVttiO4-QBIdZ2dIiiCXXT3qI4vqxBnQtJi9qPxReBr8Q5ScuKKiReIiW-xHHunPud88sdIa-kn2nGQHsggsALJDOejiLp-QC5ig1wYdz_zqNP4fAs-HAhL_78Ht0-wGpnaOfqSZ2V04Plt9VbnPBvXMSJ_vYwL66uFo6l5WiRgcIX8k30S8rVMxi1YP9Lg4WFqCtusjAMPLTkoPluufMiW36qTue_C4P-TaW85puO75I7Laik7xoruEdugL1PbjVlJlcPyK8hBpulN1i2pFdLZzk97XuMnlR0rR8w1K3JUgSE9KNjElVOarCcuMRA2JhaQ_uryvnBZvmQnk7AztwSbi3ZK8qsLgVmL2mvjwiv2x33PtPi_OcPdcC7dOSo8enUu9bfif2OkTqqlo5pD6bYY2Fpm62XDsFxvedFRY_oeVEuKhRveGP2IRkfD8a9odcWcvAyhF9zfNVDHimuIdQ6lin3gWuNUC2FXIAfxVEEkhuhfGBSm1yyMOMg_TzQApRIxSOyZ2cWnhDqZwGLfMHzWDEX_Glu0lgGWaYiDVypDjlcay3J2iTnrtbGNMFgx-k5qfWcOD0ntZ475PXmjK9Ngo9_yB45Q9jIudTc9YFZeZm0Mz0RBnCIOJYMY-9UKq1SnxtlUsMMmp_ukJdrM0pwKrvvM6mF2aLCjjA-FJyFskMeN2a16YrHIQsR2neI2jK4rXvZbrHFpE4XLqMwCqR8-h8DfUZuux3HtWPxc7I3LxfwAsHXXO_Xixa4fX_B9uv59RvW3TFP
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyper-Expression+of+PD-1+Is+Associated+with+the+Levels+of+Exhausted+and+Dysfunctional+Phenotypes+of+Circulating+CD161%2B%2BTCR+iV%CE%B17.2%2B+Mucosal-Associated+Invariant+T+Cells+in+Chronic+Hepatitis+B+Virus+Infection&rft.jtitle=Frontiers+in+immunology&rft.au=Yong%2C+Yean+K.&rft.au=Saeidi%2C+Alireza&rft.au=Tan%2C+Hong+Y.&rft.au=Rosmawati%2C+Mohamed&rft.date=2018-03-19&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=9&rft_id=info:doi/10.3389%2Ffimmu.2018.00472&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2018_00472
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon